Back

Effect of alirocumab on quantitative flow ratio and diameter stenosis in non-infarct related arteries from patients with acute myocardial infarction: a PACMAN-AMI randomized clinical trial substudy

25 August 2023 (07:30 - 18:30)
Organised by: Logo
Congress Presentation Part of: Invasive imaging assisting revascularisation in chronic coronary syndrome Coronary Circulation, Flow, and Flow Reserve ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Sarah Bar

Bern University Hospital, Inselspital, Bern (Switzerland)

6 More presentations in this session

Presentation thumbnail
Road map fusion imaging in PCI reduces contrast medium exposure irrespective of investigator's experience level
Doctor R. Phinicarides (Duesseldorf, DE)
Abstract Slides Video
Presentation thumbnail
Residual Microvasuclar Dysfunction (RMVD) after percutaneous coronary intervention (PCI) assessed by stress- transthoracic Doppler echocardiography (S-TDE).
Doctor K. Nogami (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Functional Syntax score based on quantitative flow ratio vs. anatomical Syntax score
Doctor D. Terentes-Printzios (Athens, GR)
Abstract Slides Video
Presentation thumbnail
High resting coronary flow velocity and reduced coronary flow velocity reserve independently predict worse survival in diabetic patients without inducible ischemia and normal left ventricular function
Doctor L. Meola (Lucca, IT)
Abstract Slides Video
Presentation thumbnail
Clinical outcomes of physiology-guided coronary revascularization in patients undergoing TAVR
Doctor Y. Matsuo (Kishiwada, JP)
Abstract Slides Video

Access the full session

Session thumbnail
Invasive imaging assisting revascularisation in chronic coronary syndrome

The Event

Event poster

ESC Congress 2023

25 August - 28 August 2023
You may be interested in
thumbnail
Congress Presentation
A meta analysis of effects of high-intensity statin and pcsk-9 inhibitor therapies on coronary plaque burden
thumbnail
Congress Presentation
PCSK9 inhibitors and coronary atherosclerotic plaque modification: a meta-analysis
thumbnail
Congress Presentation
Very short-term effects of single dose of proprotein convertase subtilisin kexin 9 inhibitor therapy before percutaneous coronary intervention

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources